#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Harriet Flynn Email
Operations Project Manager . Aptamer Group Ltd
York,
Locationh************@aptamergroup.co.uk
Primary EmailHow to contact Harriet Flynn
Join and see Harriet's contact info for free!Current Roles
Employees:
44Revenue:
$6.8MAbout
Aptamer Group brings together various aptamer technology driven companies to provide a range of services to the life sciences industry. Over the coming decades aptamer technology will have a profound effect on the life science market helping provide more cost-effective solutions to end users. We aim to address market needs through our group which has companies specialising in: the provision of high quality R&D consumables and high throughput aptamer screening services through Aptasol, biomarker discovery and validation tools (Aptasort), diagnostics devices / reagents (Aptadx) and therapeutic lead compounds (Aptarx). Aptamers are nucleic acid molecules made from DNA or RNA. Aptamers bind to other molecules with a higher degree of specificity and sensitivity than antibodies. Aptamers also have few of the drawbacks associated with antibodies, making them suitable replacements in many applications. The aptamers we develop are used in a variety of areas of life sciences research ranging from R&D consumables; such as, fluorescence microscopy &, flow cytometry probes through to purification (immunoprecipitation-like) reagents. We develop aptamers for use in clinical and non-clinical diagnostics and as candidate molecules for targeted therapeutics. We have also developed a first in-kind biomarker discovery process, which is set to breathe new life into the proteomics market. Our aptamers are currently being used in a variety of scenarios where antibodies have failed and are being expertly combined with microfluidics, electrochemical sensors and various nanotechnologies. The manufacturing costs and development times for monoclonal antibodies are several times higher and several times longer than the corresponding aptamer-based solution. Low manufacturing costs and speed of delivery means aptamers can be used at some point along the drug discovery process to facilitate the development of diagnostics and treatments. Get our newsletter: https://aptamergroup.com/newsletterAptamer Group Ltd Address
Innovation WayYork, null